Recent declines in New York City infant mortality rates

Pediatrics

Volumn 101, Issue 4 I, 1998, Pages 682-688

  Racine, Andrew D ^a   Joyce, Theodore J ^b,c   Li, Wenhui ^d   Chiasson, Mary Ann ^d  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b CITY UNIVERSITY OF NEW YORK   (United States)

^c NATIONAL BUREAU OF ECONOMIC RESEARCH   (United States)

^d NEW YORK CITY DEPARTMENT OF HEALTH AND MENTAL HYGIENE   (United States)

Author keywords

Infant mortality; Low birth weight

Indexed keywords

ARTICLE; BIRTH WEIGHT; CHILD CARE; ETHNOLOGY; INFANT MORTALITY; LOW BIRTH WEIGHT; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; STATISTICAL ANALYSIS; UNITED STATES; VERY LOW BIRTH WEIGHT;

AFRICAN AMERICANS; BIRTH WEIGHT; COHORT STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; HISPANIC AMERICANS; HUMANS; INFANT; INFANT MORTALITY; INFANT, LOW BIRTH WEIGHT; INFANT, NEWBORN; LOGISTIC MODELS; NEW YORK CITY;

EID: 0031893692     PISSN: 00314005     EISSN: None     Source Type: Journal    
DOI: 10.1542/peds.101.4.682     Document Type: Article

References (31)

1. New York City Department of Health. Summary of vital statistics 1976. New York, 1977. Summary of Vital Statistics 1988. New York, NY; 1989
2. US Bureau of the Census. Statistical Abstract of the United States. 115th ed. Washington, DC; 1995
3. Kotelchuck M. An evaluation of the Kessner adequacy of prenatal care index and a proposed adequacy of prenatal care utilization index. Am J Public Health. 1994;84:414-420
4. Schoendorf KC, Kiely JL. Birth weight and age-specific analysis of the 1990 US infant mortality drop. Arch Pediatr Adolesc Med. 1997;151: 129-134
5. MacDorman MF, Rowley DL, Iyasu S, et al. Infant mortality. In: Wilcox LS, Marks JS, eds. From Data to Action: CDC's Public Health Surveillance for Women, Infants, and Children. Atlanta, GA: Department of Health and Human Services, Public Health Service, Centers for Disease Control and Prevention; 1994:231-249
6. American Academy of Pediatrics. Committee on Infectious Diseases. Hemophilus influenza type b conjugate vaccine. Pediatrics. 1988;81: 908-911
7. American Academy of Pediatrics. Committee on Infectious Diseases and Committee on Fetus and Newborn. Guidelines for prevention of group B streptococcal (GBS) infection by chemoprophylaxis. Pediatrics. 1992;90:775-778
8. American Academy of Pediatrics. AAP Task Force on Infant Positioning and SIDS. Positioning and SIDS. Pediatrics. 1992;89:1120-1126
9. Guyer B, Strobino DM, Ventura SJ, MacDorman M, Martin JA. Annual summary of vital statistics. Pediatrics. 1996;98:1007-1019
10. Hallman M, Merritt A, Jarvenpaa A-L, et al. Exogenous human surfactant for treatment of severe respiratory distress syndrome: a randomized prospective clinical trial. J. Pediatr. 1985;106:963-969
11. Merritt TA, Hallman M, Bloom BT, et al. Prophylactic treatment of very premature infants with human surfactant. New Engl J Med. 1986;315: 785-790
12. Gitlin JD, Soll RF, Parad RB, et al. Randomized controlled trial of exogenous surfactant for the treatment of hyaline membrane disease. Pediatrics. 1987;79:31-37
13. Horbar JD, Soll RF, Sutherland JM, et al. A multicenter randomized, placebo-controlled trial of surfactant therapy for respiratory distress syndrome. New Engl J Med. 1989;320:959-965
14. Soll RF, Hoekstra RE, Fangman JJ, et al. Multicenter trial of single-dose modified bovine surfactant extract (Survanta) for prevention of respiratory distress syndrome. Pediatrics. 1990;85:1092-1102
15. Long W, Corbet A, Cotton A, et al. A controlled trial of synthetic surfactant in infants weighing 1250 g or more with respiratory distress syndrome. New Engl J Med. 1991;325:1696-1703
16. Speer CP, Robertson B, Curstedt T, et al. Randomized European multicenter trial of surfactant replacement therapy for severe neonatal respiratory distress syndrome: single versus multiple doses of Curosurf. Pediatrics. 1992;89:13-20
17. Horbar JD, Wright EC, Onstad L, Members of the National Institute of Child Health and Human Development Neonatal Research Network. Decreasing mortality associated with the introduction of surfactant therapy: an observational study of neonates weighing 601 to 1300 grams at birth. Pediatrics. 1993;92:191-196
18. Palta M, Weinstein JR, McGuinness G, et al. A population study: mortality and morbidity after availability of surfactant therapy. Arch Pediatr Adolesc Med. 1994;148:1295-1301
19. Schwartz RM, Luby AM, Scanlon JW, Kellogg RJ. Effect of surfactant on morbidity, mortality and resource use in newborn infants weighing 500 to 1500 grams. New Engl J Med. 1994;330:1476-1480
20. Rosenberg KD, Kalter H, Na Y, et al. The effect of surfactant on birth-weight-specific neonatal mortality rate, NYC. Presented at Annual Meetings of American Public Health Association; November 2, 1994; Washington, DC
21. Hamvas A, Wise PH, Yang RK, et al. The influence of the wider use of surfactant therapy on neonatal mortality among blacks and whites. New Engl J Med. 1996;334:1635-1640
22. Currie J, Gruber J. Health insurance eligibility, utilization of medical care, and child health. Q J Economics. 1996;111:431-466
23. Braveman PA, Egerter S, Bennett T, Showstack J. Differences in hospital resource allocation among sick newborns according to insurance coverage. JAMA. 1991;266:3300-3308
24. Collins JW, Shay DK. Prevalence of low birth weight among Hispanic infants with United States-born and foreign-born mothers: the effect of urban poverty. Am J Epidemiol. 1994;139:184-192
25. McCalla S, Minkoff HL, Feldman J, et al. The biologic and social consequences of perinatal cocaine use in an inner-city population: results of an anonymous cross-sectional study. Am J Obstet Gynecol. 1991;164: 625-630
26. McCalla S, Feldman J, Webbeh H, Ahmadi R, Minkoff HL. Changes in perinatal cocaine use in an inner-city hospital, 1988 to 1992. Am J Public Health. 1995;85:1695-1697
27. MacGregor SN, Keith LG, Chasnoff IJ, et al. Cocaine use during pregnancy: adverse perinatal outcome. Am J Obstet Gynecol. 1987;157: 686-690
28. Cherukuri R, Minkoff H, Feldman J, et al. A cohort study of alkaloidal cocaine ("crack") in pregnancy. Am J Obstet Gynecol. 1988;72:147-151
29. Bateman D, Ng S, Hansen C, Haegarty M. The effects of intrauterine cocaine exposure in newborns. Am J Public Health. 1993;83:190-193
30. Joyce T, Racine AD, Mocan N. The consequences and costs of maternal substance abuse in New York City: a pooled time-series, cross-section analysis. J Health Economics. 1992;11:297-314
31. Sumits T, Bennett R, Gould J. Maternal risks for very low birth weight infant mortality. Pediatrics. 1996;98:236-241